Predictive factors of postoperative outcome in the elderly after resective epilepsy surgery

Rev Neurol (Paris). 2022 Jun;178(6):609-615. doi: 10.1016/j.neurol.2021.08.011. Epub 2021 Nov 17.

Abstract

Objective: To evaluate the efficiency of resective epilepsy surgery (RES) in patients over 50 years and determine prognostic factors.

Results: Over the 147 patients over 50 years (54.9±3.8 years [50-69]) coming from 8 specialized French centres for epilepsy surgery, 72.1%, patients were seizure-free and 91.2% had a good outcome 12 months after RES. Seizure freedom was not associated with the age at surgery or duration of epilepsy. In multivariate analysis, seizure freedom was associated with MRI and neuropathological hippocampal sclerosis (HS) (P=0.009 and P=0.028 respectively), PET hypometabolism (P=0.013), temporal epilepsy (P=0.01). On the contrary, the need for intracranial exploration was associated with a poorer prognosis (P=0.001). Postoperative number of antiepileptic drugs was significantly lower in the seizure-free group (P=0.001). Neurological adverse event rate after surgery was 21.1% and 11.7% of patients had neuropsychological adverse effects overall transient.

Conclusions: RES is effective procedure in the elderly. Even safe it remains at higher risk of complication and population should be carefully selected. Nevertheless, age should not be considered as a limiting factor, especially when good prognostic factors are identified.

Keywords: Drug-resistant epilepsy; Elderly; Epilepsy surgery; Lobectomy.

MeSH terms

  • Aged
  • Anticonvulsants / therapeutic use
  • Electroencephalography / methods
  • Epilepsy* / complications
  • Epilepsy, Temporal Lobe* / complications
  • Humans
  • Magnetic Resonance Imaging
  • Retrospective Studies
  • Seizures / epidemiology
  • Seizures / etiology
  • Seizures / surgery
  • Treatment Outcome

Substances

  • Anticonvulsants